# Stimulant Oxytocin Study

> **NCT03016598** · PHASE2 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 42 (actual)

## Conditions studied

- Stimulant Use & Co-occuring Opioid Use Disorders

## Interventions

- **DRUG:** Intranasal oxytocin
- **DRUG:** Intranasal placebo

## Key facts

- **NCT ID:** NCT03016598
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-26
- **Primary completion:** 2020-02-14
- **Final completion:** 2020-02-14
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03016598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03016598, "Stimulant Oxytocin Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03016598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*